Literature DB >> 10702065

Biliary tract cancers.

J Figueras, C Valls, E Jaurrieta.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10702065     DOI： 10.1056/NEJM200003023420916

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  The tyrosine kinase c-Met contributes to the pro-tumorigenic function of the p38 kinase in human bile duct cholangiocarcinoma cells.

Authors:  Rongyang Dai; Juanjuan Li; Jing Fu; Yao Chen; Ruoyu Wang; Xiaofang Zhao; Tao Luo; Junjie Zhu; Yibin Ren; Jie Cao; Youwen Qian; Ning Li; Hongyang Wang
Journal:  J Biol Chem       Date:  2012-09-28       Impact factor: 5.157

2.  Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun pathway in cholangiocarcinoma.

Authors:  Kai Wei; Mao Li; Margot Zöller; Meng Wang; Arianeb Mehrabi; Katrin Hoffmann
Journal:  Cell Death Dis       Date:  2019-03-08       Impact factor: 8.469
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.